Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbb32755ecbda278fd15cfcfd3d6f1d7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-00 |
filingDate |
2019-09-27^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_464b3bbd6d39ed9f17afc9fcd2107a1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e3e92961adceb2b2fab32ff1ae92159 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d18f3930c9d550dc8d38b21792b5e963 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e22cd91d929ebe3a5be5da4c0f60b5d8 |
publicationDate |
2020-01-03^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-110642822-A |
titleOfInvention |
A group of sesquiterpenoids and their preparation method and application |
abstract |
The invention belongs to the technical field of medicine, and provides a group of sesquiterpene compounds and a preparation method and application thereof. The sesquiterpene compounds extracted from Trilobite chrysanthemum are identified through physical and chemical constants and modern spectroscopy, and the physical and chemical properties of the sesquiterpene compounds are identified. properties and chemical structures, and through pharmacodynamic tests, it was found that this group of sesquiterpenoids has anti-tumor and anti-inflammatory activities, and can be used to prepare anti-tumor and anti-inflammatory drugs. The inflammation associated with Alzheimer's disease has good pharmaceutical activity and can also be used to prepare anti-Alzheimer's disease drugs. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113387915-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113801130-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113387915-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112920146-A |
priorityDate |
2019-09-27^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |